Overview

Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and the efficacy of Tretinoin and Pioglitazone HCL in patients with ALS who are currently on Riluzole.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Phoenix Neurological Associates, LTD
Treatments:
Pioglitazone
Tretinoin